Study details
Enrolling now
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Navigator Medicines, Inc.
NCT IDNCT07384975ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Ages
18–70
Locations
10 sites in AZ, FL, KY +2
What this study is about
This Phase 2 study is focused on people with hidradenitis suppurativa.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Change from baseline in AN count, Change from baseline in the number of draining tunnels, Proportion of participants achieving skin pain numeric rating scale (NRS) 30 response